Muhammad Sarim Ansari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Sarim Ansari has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ghazala Irfan
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
5 shared publications - Faisal Qadir
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
4 shared publications - Ahmed Mohammed Ahmed
National Institute of Cardiovascular Diseases, Karachi, Pakistan
3 shared publications - Arshad Ali
National Institute of Cardiovascular Diseases, Karachi, Pakistan
3 shared publications - Azam Shafquat
National Institute of Cardiovascular Diseases, Karachi, Pakistan
3 shared publications - Reema Qayoom
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
3 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (5) , 1691-1702
Electrocardiographic Predictors of Concealed Left-Sided Accessory Pathways in Patients with Narrow-Complex Tachycardia: Development and Internal Validation of the CLAP Score
Objectives: Aim of this study was to identify electrocardiographic predictors of electrophysiological study (EPS)-confirmed concealed left-sided accessory pathways in patients with narrow-complex tachycardia and to develop and internally validate an ECG-based prediction score. Methodology: This cross-sectional diagnostic accuracy and prediction-model development study included 290 consecutive adults undergoing EPS for narrow-complex tachycardia. Twelve-lead ECGs recorded during tachycardia were independently evaluated by two electrophysiologists blinded to EPS findings. Candidate ECG predictors included RP interval, pseudo-R wave in V1, pseudo-S waves in the inferior leads, ST-segment depression, P-wave morphology, and heart rate. The primary outcome was an EPS-confirmed concealed left-sided accessory pathway. Results: Among 290 patients, 238 (82.1%) had atrioventricular nodal reentrant tachycardia (AVNRT), 29 (10.0%) had left-sided atrioventricular reentrant tachycardia (AVRT), 12 (4.1%) had right-sided AVRT, and 11 (3.8%) had non-inducible tachycardia. Absence of a pseudo-R wave in V1 was independently associated with a concealed left-sided accessory pathway (adjusted OR 16.14, 95% CI 1.95–133.27; p=0.010), as was an intermediate RP interval (>90 ms but RP < PR; adjusted OR 13.72, 95% CI 4.56–41.28; p200 beats/minute were retained in the exploratory CLAP score but did not reach statistical significance in the multivariable model. The resulting 0–6-point CLAP score assigned 2 points each for intermediate RP interval and absence of pseudo-R wave in V1 and 1 point each for ST-segment depression and heart rate >200 beats/minute. At a cutoff of ≥4, the score demonstrated 79.31% sensitivity, 88.51% specificity, 43.40% positive predictive value, and 97.47% negative predictive value. Discrimination across the complete score range was high (AUC 0.938, 95% CI 0.902–0.974), with an optimism-corrected AUC of 0.938, calibration intercept of 0.012, and calibration slope of 0.983 after bootstrap internal validation. Conclusion: Selected ECG characteristics recorded during narrow-complex tachycardia were associated with EPS-confirmed concealed left-sided accessory pathways. The preliminary CLAP score demonstrated promising discrimination and internal calibration in this single-center cohort.
- 3 October 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (5) , 1691-1702
Open AccessElectrocardiographic Predictors of Concealed Left-Sided Accessory Pathways in Patients with Narrow-Complex Tachycardia: Development and Internal Validation of the CLAP Score
Objectives: Aim of this study was to identify electrocardiographic predictors of electrophysiological study (EPS)-confirmed concealed left-sided accessory pathways in patients with narrow-complex tachycardia and to develop and internally validate an ECG-based prediction score. Methodology: This cross-sectional diagnostic accuracy and prediction-model development study included 290 consecutive adults undergoing EPS for narrow-complex tachycardia. Twelve-lead ECGs recorded during tachycardia were independently evaluated by two electrophysiologists blinded to EPS findings. Candidate ECG predictors included RP interval, pseudo-R wave in V1, pseudo-S waves in the inferior leads, ST-segment depression, P-wave morphology, and heart rate. The primary outcome was an EPS-confirmed concealed left-sided accessory pathway. Results: Among 290 patients, 238 (82.1%) had atrioventricular nodal reentrant tachycardia (AVNRT), 29 (10.0%) had left-sided atrioventricular reentrant tachycardia (AVRT), 12 (4.1%) had right-sided AVRT, and 11 (3.8%) had non-inducible tachycardia. Absence of a pseudo-R wave in V1 was independently associated with a concealed left-sided accessory pathway (adjusted OR 16.14, 95% CI 1.95–133.27; p=0.010), as was an intermediate RP interval (>90 ms but RP < PR; adjusted OR 13.72, 95% CI 4.56–41.28; p200 beats/minute were retained in the exploratory CLAP score but did not reach statistical significance in the multivariable model. The resulting 0–6-point CLAP score assigned 2 points each for intermediate RP interval and absence of pseudo-R wave in V1 and 1 point each for ST-segment depression and heart rate >200 beats/minute. At a cutoff of ≥4, the score demonstrated 79.31% sensitivity, 88.51% specificity, 43.40% positive predictive value, and 97.47% negative predictive value. Discrimination across the complete score range was high (AUC 0.938, 95% CI 0.902–0.974), with an optimism-corrected AUC of 0.938, calibration intercept of 0.012, and calibration slope of 0.983 after bootstrap internal validation. Conclusion: Selected ECG characteristics recorded during narrow-complex tachycardia were associated with EPS-confirmed concealed left-sided accessory pathways. The preliminary CLAP score demonstrated promising discrimination and internal calibration in this single-center cohort.
- Open Access
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 765-770
Gender Differences in Clinical Presentation, Healthcare-Seeking Behavior, and Management of Supraventricular Tachycardia Among Patients Undergoing Catheter Ablation in a Lower–Middle-Income Country
Objectives: Supraventricular tachycardia (SVT) is a common cardiac arrhythmia originating at or above the atrioventricular node and is characterized by a narrow QRS complex and rapid heart rate. This study aimed to assess gender differences in clinical presentation, healthcare-seeking behavior, management patterns, and outcomes among patients undergoing catheter ablation for SVT. Methodology: This cross-sectional observational study was conducted at a tertiary-care cardiac center in Karachi, Pakistan, between November 2022 and May 2023. Adult patients (≥18 years) who underwent successful catheter ablation for SVT were enrolled. Data were collected using a structured questionnaire capturing demographic characteristics, symptom profiles, treatment delays, compliance with antiarrhythmic drugs, and patient preferences regarding physician gender. Results: A total of 198 patients were included, of whom 68.2% were women and 31.8% were men. Women were significantly older than men and reported a higher burden of symptoms, including shortness of breath and dizziness. Despite this, women experienced substantially longer delays from symptom onset to first medical consultation and from electrophysiology evaluation to catheter ablation. Affordability and family-related factors contributed to delayed care among women. Medication adherence differed markedly by gender, with high compliance among women and poor adherence among men. Most patients reported no preference regarding the gender of the treating physician. Conclusion: Significant gender disparities exist in the management of SVT, with women experiencing greater delays in diagnosis and definitive treatment despite more severe symptomatology. Addressing sociocultural and systemic barriers to timely care may improve equity and outcomes for patients with SVT in resource-limited settings.
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 765-770
Open AccessGender Differences in Clinical Presentation, Healthcare-Seeking Behavior, and Management of Supraventricular Tachycardia Among Patients Undergoing Catheter Ablation in a Lower–Middle-Income Country
Objectives: Supraventricular tachycardia (SVT) is a common cardiac arrhythmia originating at or above the atrioventricular node and is characterized by a narrow QRS complex and rapid heart rate. This study aimed to assess gender differences in clinical presentation, healthcare-seeking behavior, management patterns, and outcomes among patients undergoing catheter ablation for SVT. Methodology: This cross-sectional observational study was conducted at a tertiary-care cardiac center in Karachi, Pakistan, between November 2022 and May 2023. Adult patients (≥18 years) who underwent successful catheter ablation for SVT were enrolled. Data were collected using a structured questionnaire capturing demographic characteristics, symptom profiles, treatment delays, compliance with antiarrhythmic drugs, and patient preferences regarding physician gender. Results: A total of 198 patients were included, of whom 68.2% were women and 31.8% were men. Women were significantly older than men and reported a higher burden of symptoms, including shortness of breath and dizziness. Despite this, women experienced substantially longer delays from symptom onset to first medical consultation and from electrophysiology evaluation to catheter ablation. Affordability and family-related factors contributed to delayed care among women. Medication adherence differed markedly by gender, with high compliance among women and poor adherence among men. Most patients reported no preference regarding the gender of the treating physician. Conclusion: Significant gender disparities exist in the management of SVT, with women experiencing greater delays in diagnosis and definitive treatment despite more severe symptomatology. Addressing sociocultural and systemic barriers to timely care may improve equity and outcomes for patients with SVT in resource-limited settings.
- Open Access
- 1 May 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (2) , 362-370
Management and Outcomes of Cardiac Implantable Electronic Device Infections without Specialized Lead Extraction Tools in a Resource-Limited Setting: A Single-Center Retrospective Study
Objectives: To evaluate management strategies and clinical outcomes of patients with CIED infections treated without specialized lead extraction tools in a resource-limited tertiary care setting. Methodology: This single-center retrospective study included patients admitted with CIED infection at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, between June 2023 and October 2025. Patients were categorized according to management strategy: Group 1 (no complete hardware removal) and Group 2 (complete hardware removal). Follow-up was conducted through outpatient clinic visits and structured telephone interviews. Clinical outcomes included procedural success, in-hospital mortality, infection persistence, recurrence, and follow-up mortality. Results: A total of 53 patients were analyzed (mean age 58.2 ± 17.2 years; 56.6% male). Complete hardware removal was achieved in 37 patients (69.8%), while 16 patients (30.2%) underwent partial removal or debridement only. Of 99 indwelling leads, 71 (71.7%) were successfully extracted using manual traction techniques. Median dwell time of explanted leads was 136 days [19–1198]. In-hospital mortality occurred in 3 patients (5.6%). During follow-up (median 173 days), persistence of infection occurred in 4 patients (8.5%), and recurrence was observed in 3 patients (6.4%). Infection persistence was significantly more frequent in patients without complete hardware removal. Conclusion: In this resource-limited setting, complete hardware removal was feasible in approximately two-thirds of CIED infections without specialized extraction tools and was associated with lower infection persistence. While outcomes appear acceptable, findings should be interpreted cautiously given the retrospective design and limited sample size.
- 1 May 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (2) , 362-370
Open AccessManagement and Outcomes of Cardiac Implantable Electronic Device Infections without Specialized Lead Extraction Tools in a Resource-Limited Setting: A Single-Center Retrospective Study
Objectives: To evaluate management strategies and clinical outcomes of patients with CIED infections treated without specialized lead extraction tools in a resource-limited tertiary care setting. Methodology: This single-center retrospective study included patients admitted with CIED infection at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, between June 2023 and October 2025. Patients were categorized according to management strategy: Group 1 (no complete hardware removal) and Group 2 (complete hardware removal). Follow-up was conducted through outpatient clinic visits and structured telephone interviews. Clinical outcomes included procedural success, in-hospital mortality, infection persistence, recurrence, and follow-up mortality. Results: A total of 53 patients were analyzed (mean age 58.2 ± 17.2 years; 56.6% male). Complete hardware removal was achieved in 37 patients (69.8%), while 16 patients (30.2%) underwent partial removal or debridement only. Of 99 indwelling leads, 71 (71.7%) were successfully extracted using manual traction techniques. Median dwell time of explanted leads was 136 days [19–1198]. In-hospital mortality occurred in 3 patients (5.6%). During follow-up (median 173 days), persistence of infection occurred in 4 patients (8.5%), and recurrence was observed in 3 patients (6.4%). Infection persistence was significantly more frequent in patients without complete hardware removal. Conclusion: In this resource-limited setting, complete hardware removal was feasible in approximately two-thirds of CIED infections without specialized extraction tools and was associated with lower infection persistence. While outcomes appear acceptable, findings should be interpreted cautiously given the retrospective design and limited sample size.
- Open Access
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 98-105
Patient Perceptions of Reprocessed Electrophysiology Catheters in a Public-Sector Cardiac Center: Cost and Waiting-Time Trade-Offs in a Low–Middle Income Country
Objectives: This study aimed to assess patient perceptions toward the use of reprocessed EP catheters and, when deemed unacceptable, to evaluate their willingness to pay additional procedural costs for new catheters or to tolerate extended waiting times until new catheters became available. Methodology: We conducted a cross-sectional survey of 100 consecutive adult patients who underwent electrophysiology study (EPS) with or without catheter ablation for supraventricular tachycardia at a tertiary public cardiac center in Karachi, Pakistan. A structured questionnaire in the local language (Urdu) was administered post-procedure to evaluate perceptions regarding reprocessed catheters, willingness to pay additional costs for new catheters, and acceptable waiting periods for free-of-cost new catheters. Results: Among 100 participants (mean age 45.2 ± 14.0 years; 60% female), 57% reported that reprocessed catheters “can be used” if their physician was satisfied with safety, while 40% believed they “should not be used,” and 3% were uncertain. The most common concerns among those opposed were infection risk (77.5%), concerns regarding adequacy of reprocessing protocols (55%), and perceived inefficiency (42.5%). When presented with financial trade-offs, 41% preferred reprocessed catheters rather than making additional out-of-pocket payments. Only 2% were willing to pay the full cost of new catheters. Regarding waiting time, 65% preferred immediate use of reprocessed catheters rather than delaying treatment for new devices. Conclusion: Although a substantial proportion of patients expressed concerns regarding reuse, practical considerations including financial limitations and urgency of symptom relief, significantly influenced preferences. Clear communication regarding safety protocols and shared decision-making may enhance patient acceptance of reprocessed catheters while improving cost-effectiveness and access to electrophysiology services in resource-limited settings.
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 98-105
Open AccessPatient Perceptions of Reprocessed Electrophysiology Catheters in a Public-Sector Cardiac Center: Cost and Waiting-Time Trade-Offs in a Low–Middle Income Country
Objectives: This study aimed to assess patient perceptions toward the use of reprocessed EP catheters and, when deemed unacceptable, to evaluate their willingness to pay additional procedural costs for new catheters or to tolerate extended waiting times until new catheters became available. Methodology: We conducted a cross-sectional survey of 100 consecutive adult patients who underwent electrophysiology study (EPS) with or without catheter ablation for supraventricular tachycardia at a tertiary public cardiac center in Karachi, Pakistan. A structured questionnaire in the local language (Urdu) was administered post-procedure to evaluate perceptions regarding reprocessed catheters, willingness to pay additional costs for new catheters, and acceptable waiting periods for free-of-cost new catheters. Results: Among 100 participants (mean age 45.2 ± 14.0 years; 60% female), 57% reported that reprocessed catheters “can be used” if their physician was satisfied with safety, while 40% believed they “should not be used,” and 3% were uncertain. The most common concerns among those opposed were infection risk (77.5%), concerns regarding adequacy of reprocessing protocols (55%), and perceived inefficiency (42.5%). When presented with financial trade-offs, 41% preferred reprocessed catheters rather than making additional out-of-pocket payments. Only 2% were willing to pay the full cost of new catheters. Regarding waiting time, 65% preferred immediate use of reprocessed catheters rather than delaying treatment for new devices. Conclusion: Although a substantial proportion of patients expressed concerns regarding reuse, practical considerations including financial limitations and urgency of symptom relief, significantly influenced preferences. Clear communication regarding safety protocols and shared decision-making may enhance patient acceptance of reprocessed catheters while improving cost-effectiveness and access to electrophysiology services in resource-limited settings.
- Open Access
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 81-87
Pharmacological Agents for Induction of Supraventricular Tachycardia during Electrophysiology Study: A Retrospective Cohort Analysis
Objectives: Most supraventricular tachycardia (SVT) can be induced using standard electrophysiological pacing maneuvers, pharmacological agents are often required when tachycardia is not inducible at baseline. This study aimed to evaluate the need for pharmacological agents and to determine their success rates in inducing SVT during EPS among patients in whom tachycardia could not be induced using standard electrophysiological maneuvers. Methodology: A retrospective cohort study was conducted at the National Institute of Cardiovascular Diseases, Karachi, including patients who underwent EPS for SVT induction between 1st January 2022 and 31st December 2023. Of 1,217 EPS procedures performed, 1,201 patients were included after excluding cases with incomplete data or repeat procedures. The primary outcomes were the proportion of patients requiring pharmacological induction and the success rate of SVT induction following drug administration. Results: The mean age of the cohort was 42.9 ± 17.1 years, with a female predominance (59.4%). SVT was successfully induced using electrophysiological maneuvers alone in 939 patients (78.2%). Pharmacological agents were required in 262 patients (21.8%), with an overall induction success rate of 38.2% in this subgroup. Atropine was administered in 245 cases and successfully induced SVT in 100 patients (40.8%). Metoprolol and epinephrine did not result in successful induction. Among pharmacologically induced SVTs, atrioventricular nodal reentrant tachycardia (AVNRT) was the most common subtype. Conclusion: Most SVTs can be induced using electrophysiological maneuvers alone. In cases refractory to pacing, atropine facilitated SVT induction in a limited proportion of patients, while other agents demonstrated minimal utility.
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 81-87
Open AccessPharmacological Agents for Induction of Supraventricular Tachycardia during Electrophysiology Study: A Retrospective Cohort Analysis
Objectives: Most supraventricular tachycardia (SVT) can be induced using standard electrophysiological pacing maneuvers, pharmacological agents are often required when tachycardia is not inducible at baseline. This study aimed to evaluate the need for pharmacological agents and to determine their success rates in inducing SVT during EPS among patients in whom tachycardia could not be induced using standard electrophysiological maneuvers. Methodology: A retrospective cohort study was conducted at the National Institute of Cardiovascular Diseases, Karachi, including patients who underwent EPS for SVT induction between 1st January 2022 and 31st December 2023. Of 1,217 EPS procedures performed, 1,201 patients were included after excluding cases with incomplete data or repeat procedures. The primary outcomes were the proportion of patients requiring pharmacological induction and the success rate of SVT induction following drug administration. Results: The mean age of the cohort was 42.9 ± 17.1 years, with a female predominance (59.4%). SVT was successfully induced using electrophysiological maneuvers alone in 939 patients (78.2%). Pharmacological agents were required in 262 patients (21.8%), with an overall induction success rate of 38.2% in this subgroup. Atropine was administered in 245 cases and successfully induced SVT in 100 patients (40.8%). Metoprolol and epinephrine did not result in successful induction. Among pharmacologically induced SVTs, atrioventricular nodal reentrant tachycardia (AVNRT) was the most common subtype. Conclusion: Most SVTs can be induced using electrophysiological maneuvers alone. In cases refractory to pacing, atropine facilitated SVT induction in a limited proportion of patients, while other agents demonstrated minimal utility.